Gainers
- Allarity Therapeutics ALLR stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
- DarioHealth DRIO stock rose 15.4% to $7.49. The market value of their outstanding shares is at $162.0 million. The company's, Q4 earnings came out today.
- Stealth BioTherapeutics MITO stock rose 9.11% to $0.73. The market value of their outstanding shares is at $42.0 million.
- Regulus Therapeutics RGLS shares increased by 9.05% to $0.3. The market value of their outstanding shares is at $43.7 million.
- NexGel NXGL stock rose 8.87% to $2.27. The market value of their outstanding shares is at $12.6 million. The company's, Q4 earnings came out today.
- CinCor Pharma CINC shares moved upwards by 7.96% to $16.0. The company's market cap stands at $584.3 million.
Losers
- Statera BioPharma STAB stock fell 29.3% to $0.42 during Monday's after-market session. Trading volume for this security closed at 443.1K, accounting for 61.8% of its average full-day volume over the last 100 days. The company's market cap stands at $15.0 million.
- Applied Genetic AGTC shares fell 23.34% to $1.38. This security traded at a volume of 369.5K shares come close, making up 82.1% of its average volume over the last 100 days. The company's market cap stands at $59.2 million.
- Adamis Pharmaceuticals ADMP shares fell 6.17% to $0.6. Adamis Pharmaceuticals's trading volume hit 352.1K shares by close, accounting for 20.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $89.3 million.
- Immuneering IMRX stock declined by 5.65% to $6.85. The market value of their outstanding shares is at $180.6 million.
- Orphazyme ORPH shares declined by 5.31% to $0.8. This security traded at a volume of 309.4K shares come close, making up 22.6% of its average volume over the last 100 days. The company's market cap stands at $28.2 million.
- BIMI International BIMI stock decreased by 5.15% to $1.29. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in